Clinical trial
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
NCT00058331 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00058331 |
|---|---|
| Title | Epoetin Alfa in Treating Anemia in Patients With Solid Tumors |
| Official title | A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological |
| Interventions | epoetin alfa |
| Enrollment | 365 |
| Start date | Jun 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Apr 9, 2003 |
| Last update posted | Jul 18, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: